First human test of new Vision-Saving eye injection shows promise
Disease control
Completed
This was a first-in-human study to check the safety of a new drug, OLX10212, for wet age-related macular degeneration (AMD). It involved 21 patients who received injections of the drug into their eye. The main goal was to see if the treatment was safe and tolerable, while also lo…
Phase: PHASE1 • Sponsor: Olix Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC